GlaxoSmithKline

Although many thought the era of the big mining mergers was over, some believe newly-formed GlenStrata could have its sights on Anglo-American.

Pfizer deal becomes third largest

GlaxoSmithKline, the UK's dominant drugs company, has reported a decline in fourth quarter sales and announced a share buyback programme well below analysts' expectations.

Income investors enjoyed a bumper year in 2011 as dividends from UK-listed companies hit an all-time high, surging 12.8% to £67.8bn.

The latest Dividend Monitor report from Capita Registrars has unveiled the top ten dividend paying stocks in the UK market last year.

This week saw a round of updates from some of the UK's largest dividend payers, including BP, Shell, Glaxo and British American Tobacco. But is it time for investors to be selling the big names?

GlaxoSmithKline and British American Tobacco, two of Neil Woodford's largest holdings, have reported rising revenues in the third quarter.

Jayesh Manek's £40m Manek Growth fund has soared to the top of the UK All Companies sector, losing just 2.5% in the last three months of excessive market volatility.

Simon Gergel, director at RCM, is the portfolio manager of the Merchants Trust plc. He talks to Jane Wallace about the trust's objectives and performance.

MUNDY'S MOMENT